BioFocus DPI and Medicines for Malaria Venture collaborate to identify anti-malarial compounds

20-Apr-2009 - Switzerland

BioFocus DP and the not-for-profit organization Medicines for malaria Venture (MMV) announced the start of a collaboration to identify new natural product and small molecules that demonstrate anti-malarial activity.

Prior to the collaboration, MMV had acquired access to BioFocus DPI’s natural product and SoftFocus® compound collections, which gave hits with anti-malarial activity in disease-specific assays. The aim of the current collaboration is to determine which of the small molecules in these collections show activity, with the intention to further optimize these hits as anti-malarial therapeutics.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances